Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Plain Healthcare awarded NICE Accreditation

28th Jan 2013 11:27

RNS Number : 4924W
Avia Health Informatics PLC
28 January 2013
 



28 January 2013

 

Avia Health Informatics Plc

("Avia" or the "Company")

 

Plain Healthcare awarded NICE Accreditation

 

Avia (AIM: AVIA), the developer and provider of clinical decision support and referral facilitation software, via its wholly owned subsidiary, Plain Healthcare, announces that it has achieved National Institute for Health and Clinical Excellence ("NICE") accreditation for its approach to developing and maintaining the content in its Odyssey clinical decision support system.

Following a thorough appraisal of Plain Healthcare's clinical development processes, the NICE Accreditation Advisory Committee has commended the Company for the robust and systematic methods used for searching and identifying the evidence base used to populate the Odyssey clinical database. This database is used by Odyssey to guide the assessment and interpretation of symptoms during primary care consultations with patients and the provision of advice and information.

The Odyssey suite of products has been designed specifically to address the needs of the modern NHS. Avia's expert clinical team has developed a robust product which not only improves processes and provides access to local pathways but also makes significant savings in both time and money.

Dr Carl Parker, Vice Chair, Accreditation Advisory Committee, congratulated Plain Healthcare on achieving this excellent standard of content development and assisting in validating this approach to the quality assurance of content used in decision support.

 

Professor Jeremy Dale, Chief Executive of Avia Health Informatics Plc, commented:

"We are delighted that Plain Healthcare has achieved NICE accreditation. This is testament to the safety and effectiveness of Odyssey clinical content and the hard work and commitment of our clinical team. We are committed to continuously reviewing and improving our processes to ensure the highest of standards. NICE accreditation provides validation that will be welcomed by patients, clinicians and managers of services that use Odyssey decision support."

 

-ENDS-

Enquiries:

Avia Health Informatics Plc Tel. +44 (0) 1494 618503

Professor Jeremy Dale, Chief Executive

 

Allenby Capital Limited Tel. +44 (0) 20 3328 5656

Nick Naylor, Chief Executive

Mark Connelly, Corporate Finance

 

About Avia Health Informatics Plc

 

Avia is a developer and provider of clinical decision support systems. Its Odyssey range is used by clinicians and non-clinicians in various environments around the world to provide effective healthcare support, increasing the levels of patient care while delivering operational efficiencies. The delivery of Odyssey can be in a static or mobile environment from a PC, laptop, iPad, tablet or mobile device, with clinical content, training and services delivered via the web or hosted service. Avia's, PathFinderRF offers on-line referral facilitation to manage the quality of referrals.

Avia's partners provide market reach into geographies outside of the UK, including Europe, Far East, the United States and Australia.

The Odyssey range is built on a common medical content database, which has been developed over the past 17 years. Odyssey is continually updated, tailored with question and answer sets and has a user interface adapted for the particular user groups and the environment in which it is used. Environments include prisons, ships, call centres, GP out of hours, walk in centres, care homes, pharmacies and other clinical and non-clinical environments.

For more information on Avia please visit: www.ahi-plc.com, and Plain Healthcare: http://www.plainhealthcare.co.uk/

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEDFFAFDSEEF

Related Shares:

CTFA.L
FTSE 100 Latest
Value8,275.66
Change0.00